Allergy and Immunology, Allergy · Horseheads, NY
NPI
1679675995
Since 2006
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2977 Westinghouse Rd
Horseheads, NY, 14845
Phone (607) 684-6115
Groups this clinician bills Medicare through
Medicare paid, 2024
$732K
32,459 services
Medicare patients, 2024
658
Average age 71
Drug cost, 2024
$2.2M
2,194 prescriptions
Company payments, 2025
$112K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher A Smith was code J2357 (injection, omalizumab, 5 mg), 7,590 times for 17 patients. In total Christopher A Smith billed 32,459 services in 43 codes, and Medicare paid $732K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 7,590 | 17 | $28.60 | $217K |
| 95004 Test - Miscellaneous | Office | 6,680 | 82 | $2.55 | $17K |
| 95165 Treatment - Miscellaneous | Office | 4,300 | 129 | $10.17 | $44K |
| 95117 Treatment - Miscellaneous | Office | 2,007 | 123 | $8.21 | $16K |
| J0517 Injection, benralizumab, 1 mg | Office | 1,471 | 13 | $131.13 | $193K |
| 95044 Test - Miscellaneous | Office | 703 | 11 | $3.50 | $2,460 |
| 99213 Office E&M - Established | Office | 586 | 412 | $59.91 | $35K |
| 96372 Injection Administration | Office | 545 | 57 | $10.23 | $5,576 |
| 99214 Office E&M - Established | Office | 430 | 263 | $85.33 | $37K |
| 95115 Treatment - Miscellaneous | Office | 324 | 25 | $6.98 | $2,262 |
| 95012 Pulmonary | Office | 293 | 199 | $11.50 | $3,369 |
| 94060 Pulmonary Function Testing | Office | 274 | 191 | $24.77 | $6,787 |
| 99458 E&M - Miscellaneous | Office | 212 | 26 | $28.27 | $5,994 |
| 99457 E&M - Miscellaneous | Office | 197 | 26 | $35.19 | $6,933 |
| 99454 E&M - Miscellaneous | Office | 190 | 25 | $33.46 | $6,358 |
By year: 2022 $579K for 23,715 services; 2023 $699K for 27,866 services; 2024 $732K for 32,459 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87631 Infectious Agent Detection by DNA/RNA | 40 | 37 | $126.33 | $5,053 |
Medicare prescription drug claims, 2024
In 2024, the drug Christopher A Smith prescribed most often to Medicare patients was Levocetirizine Dihydrochloride, with 471 prescriptions and refills. In total Christopher A Smith wrote 2,194 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levocetirizine Dihydrochloride Generic | 471 | 786 | 163 | $6,733 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 197 | 220 | 77 | $6,805 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 145 | 201 | 50 | $124K |
| Mometasone Furoate Generic | 130 | 182 | 50 | $8,275 |
| Desloratadine Generic | 124 | 212 | 54 | $5,225 |
| Breo Ellipta Fluticasone/Vilanterol | 115 | 160 | 33 | $59K |
| Montelukast Sodium Generic | 114 | 241 | 40 | $884 |
| Dupixent Pen Dupilumab | 67 | 69 | Under 11 | $277K |
| Fluticasone Propionate Generic | 66 | 136 | 33 | $1,422 |
| Azelastine Hcl Generic | 65 | 132 | 27 | $2,086 |
| Prednisone Generic | 59 | 64 | 40 | $307 |
| Xolair Omalizumab | 50 | 50 | Under 11 | $130K |
| Azelastine-Fluticasone Azelastine/Fluticasone | 41 | 52 | 14 | $5,363 |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 33 | 33 | Under 11 | $130K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 32 | 38 | Under 11 | $23K |
Brand drugs: - claims; generic drugs: 1,370 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher A Smith $112K ($112K in general payments such as food, travel and fees) from 27 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $66K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 104 | $66K |
| Genzyme Corporation SNY | 42 | $40K |
| GlaxoSmithKline, LLC. GSK | 25 | $3,580 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 15 | $359 |
| Regeneron Pharmaceuticals, Inc. REGN | 2 | $237 |
| Amgen Inc. AMGN | 10 | $221 |
| Pfizer Inc. PFE | 9 | $201 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $188 |
| BioCryst US Sales Co., LLC | 7 | $168 |
| CSL Behring CSL.AX | 8 | $168 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.